Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Early-onset pancreatic cancer: A national cancer registry study from the Czech Republic and review of the literature

A. Whitley, P. Kocián, A. Nikov, D. Krejčí, L. Pehalová, M. Blaha, L. Dušek, R. Gürlich

. 2023 ; 30 (12) : 1324-1333. [pub] 20230926

Jazyk angličtina Země Japonsko

Typ dokumentu přehledy, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24000467

BACKGROUND: The aim of this study was to compare trends in mortality and incidence, clinicopathological features and survival of patients diagnosed with pancreatic ductal adenocarcinoma under 50 years of age (early-onset pancreatic cancer [EOPC]) with patients diagnosed over 50 years of age (late-onset pancreatic cancer [LOPC]). METHODS: The national oncological registry of the Czech Republic was reviewed to identify all patients with histologically confirmed pancreatic ductal adenocarcinoma diagnosed between the years 1985 and 2015. Incidence, mortality, clinicopathological and survival data were analyzed and compared between patients with EOPC and LOPC. RESULTS: From a total of 18 888 patients included in the study, 1324 patients were under the age of 50 years (7.0%). The average annual percentage changes (AAPC) in incidence of all patients with EOPC was -1.0%. The APPC for male patients with EOPC was -2.0% and for female patients was +0.6%. The AAPC in incidence for LOPC was +1.3%. There were no differences in tumor stage, grade or location between EOPC and LOPC. Young patients were more frequently male (64.4% vs. 52.9%), more frequently underwent treatment and had better overall survival. The median survival interval for EOPC was 5.9 months and for LOPC was 4.5 months (p < .001). CONCLUSIONS: The clinicopathological features of pancreatic ductal adenocarcinoma were similar in patients under and over the age of 50 years. Patients with EOPC survived longer than patients with LOPC. Continued efforts should be made to diagnose early and treat young patients aggressively.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24000467
003      
CZ-PrNML
005      
20240213093212.0
007      
ta
008      
240109s2023 ja f 000 0|eng||
009      
AR
024    7_
$a 10.1002/jhbp.1359 $2 doi
035    __
$a (PubMed)37750364
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ja
100    1_
$a Whitley, Adam $u Department of Surgery, University Hospital Kralovske Vinohrady, Prague, Czech Republic $u Department of Anatomy, Second Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/000000024415172X
245    10
$a Early-onset pancreatic cancer: A national cancer registry study from the Czech Republic and review of the literature / $c A. Whitley, P. Kocián, A. Nikov, D. Krejčí, L. Pehalová, M. Blaha, L. Dušek, R. Gürlich
520    9_
$a BACKGROUND: The aim of this study was to compare trends in mortality and incidence, clinicopathological features and survival of patients diagnosed with pancreatic ductal adenocarcinoma under 50 years of age (early-onset pancreatic cancer [EOPC]) with patients diagnosed over 50 years of age (late-onset pancreatic cancer [LOPC]). METHODS: The national oncological registry of the Czech Republic was reviewed to identify all patients with histologically confirmed pancreatic ductal adenocarcinoma diagnosed between the years 1985 and 2015. Incidence, mortality, clinicopathological and survival data were analyzed and compared between patients with EOPC and LOPC. RESULTS: From a total of 18 888 patients included in the study, 1324 patients were under the age of 50 years (7.0%). The average annual percentage changes (AAPC) in incidence of all patients with EOPC was -1.0%. The APPC for male patients with EOPC was -2.0% and for female patients was +0.6%. The AAPC in incidence for LOPC was +1.3%. There were no differences in tumor stage, grade or location between EOPC and LOPC. Young patients were more frequently male (64.4% vs. 52.9%), more frequently underwent treatment and had better overall survival. The median survival interval for EOPC was 5.9 months and for LOPC was 4.5 months (p < .001). CONCLUSIONS: The clinicopathological features of pancreatic ductal adenocarcinoma were similar in patients under and over the age of 50 years. Patients with EOPC survived longer than patients with LOPC. Continued efforts should be made to diagnose early and treat young patients aggressively.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    12
$a nádory slinivky břišní $x epidemiologie $x terapie $x diagnóza $7 D010190
650    12
$a duktální karcinom slinivky břišní $x epidemiologie $x terapie $7 D021441
650    _2
$a registrace $7 D012042
650    _2
$a incidence $7 D015994
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a přehledy $7 D016454
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kocián, Petr $u Department of Surgery, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000254011827 $7 xx0118297
700    1_
$a Nikov, Andrej $u Department of Surgery, University Hospital Kralovske Vinohrady, Prague, Czech Republic
700    1_
$a Krejčí, Denisa $u Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Pehalová, Lucie $u Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Blaha, Milan $u Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Dušek, Ladislav $u Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Gürlich, Robert $u Department of Surgery, University Hospital Kralovske Vinohrady, Prague, Czech Republic
773    0_
$w MED00214339 $t Journal of hepato-biliary-pancreatic sciences $x 1868-6982 $g Roč. 30, č. 12 (2023), s. 1324-1333
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37750364 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213093209 $b ABA008
999    __
$a ok $b bmc $g 2049246 $s 1210161
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 30 $c 12 $d 1324-1333 $e 20230926 $i 1868-6982 $m Journal of hepato-biliary-pancreatic sciences $n J Hepatobiliary Pancreat Sci $x MED00214339
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Možnosti archivace